Skip to content
Disclosery

ARMISTICE CAPITAL, LLC: STAA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ARMISTICE CAPITAL, LLC on STAA, newest first. How the timeline and the estimate are built.

ARMISTICE CAPITAL, LLC held 0 STAA shares at 2025-09-30 per its 13F-HR filed 2025-11-17.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -2,812,000 shares

    13F-HR 0001315863-25-000814 filed by ARMISTICE CAPITAL, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 2,812,000 shares
    Change vs previous 13F -188,000 shares

    1.79% of the 13F portfolio, value $47,185,360.

    13F-HR 0001315863-25-000629 filed by ARMISTICE CAPITAL, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 3,000,000 shares
    Change vs previous 13F +2,128,000 shares

    1.41% of the 13F portfolio, value $52,890,000.

    13F-HR 0001315863-25-000403 filed by ARMISTICE CAPITAL, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 872,000 shares
    Change vs previous 13F +375,500 shares

    0.49% of the 13F portfolio, value $21,180,880.

    13F-HR 0001315863-25-000182 filed by ARMISTICE CAPITAL, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 496,500 shares
    Change vs previous 13F not available

    0.48% of the 13F portfolio, value $18,444,975.

    13F-HR 0001315863-24-000816 filed by ARMISTICE CAPITAL, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).